Skip to main content
. 2022 Dec 12;46(Suppl 1):S19–S40. doi: 10.2337/dc23-S002

Table 2.3.

Criteria for screening for diabetes or prediabetes in asymptomatic adults

1. Testing should be considered in adults with overweight or obesity (BMI ≥25 kg/m2 or ≥23 kg/m2 in Asian American individuals) who have one or more of the following risk factors:
 • First-degree relative with diabetes
 • High-risk race/ethnicity (e.g., African American, Latino, Native American, Asian American, Pacific Islander)
 • History of CVD
 • Hypertension (≥130/80 mmHg or on therapy for hypertension)
 • HDL cholesterol level <35 mg/dL (0.90 mmol/L) and/or a triglyceride level >250 mg/dL (2.82 mmol/L)
 • Individuals with polycystic ovary syndrome
 • Physical inactivity
 • Other clinical conditions associated with insulin resistance (e.g., severe obesity, acanthosis nigricans)
2. People with prediabetes (A1C ≥5.7% [39 mmol/mol], IGT, or IFG) should be tested yearly.
3. People who were diagnosed with GDM should have lifelong testing at least every 3 years.
4. For all other people, testing should begin at age 35 years.
5. If results are normal, testing should be repeated at a minimum of 3-year intervals, with consideration of more frequent testing depending on initial results and risk status.
6. People with HIV

CVD, cardiovascular disease; GDM, gestational diabetes mellitus; IFG, impaired fasting glucose; IGT, impaired glucose tolerance.